entries are accurately reflected within SAP and adjusted accordingly in the supplier’s records Ensure compliance with country... is preferred SAP/Coupa system knowledge Experience with a multinational employer Experience working in a multicultural...
about the latest news via our . Description and Requirements 岗位职责: 1、了解和分析行业竞品、趋势和业务模式,制作解决方案销售工具; 2、负责SAP云相关解决方案的规划、设计...研发和测试理解需求,确保项目正确满足用户要求; 6、参与global方案开发团队的沟通与落地; 任职要求: 1、3年以上企业级硬件产品或解决方案相关经验,有SAP Basis/云产品相关经验优先; 2、了解主流服务器厂商关于SAP解决...
Top dividend yield stocks: Coal India and Gujarat State Fertilisers & Chemicals are on Religare Broking's list of top 10 dividend yield stocks. Continue Reading »
Budget 2024: Hemal Shah of Torus ORO PMS has suggested L&T, HDFC Bank, Canfin Homes, and Oil India ahead of the upcoming Union Budget saying that the stocks can benefit most out of the policy announcements. Continue Reading »
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »